why choose us

First received: August 22, 2023

Clinical Trial: PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea

Study Status: Completed

Recruit Status: RECRUITING

Condition: Seborrheic Dermatitis

Study Type: INTERVENTIONAL


Official Title: PDE4 Inhibition in the Treatment of Seborrheic Dermatitis and Papulopustular Rosacea With PF-07038124

Brief Summary: This study is a double-blind, vehicle-controlled clinical trial.The study will take place at Icahn School of Medicine at Mount Sinai.The study will include 33-39 adult subjects with moderate-to-severe-Seborrheic dermatitis (SD) as well as 33-39 adult subjects with moderate-to-severe papulopustular rosacea (PPR).Subjects will be randomized 2:1 to receive study drug or placebo.Enrolled subjects will apply topical PF-07038124 0.02% ointment once daily for 8 weeks.They will return for visits at weeks 4, 8, and 12…

Read more